Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Catherine Scart-Grès"'
Autor:
Josep Gamez, Matilde Calopa, Esteban Muñoz, Aileen Ferré, Oscar Huertas, Kevin McAllister, Núria Reig, Catherine Scart‐Grès, Raúl Insa, Jaime Kulisevsky
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
The study's aim is to investigate the efficacy and safety of SOM3355 (bevantolol hydrochloride), a βA randomized, placebo-controlled proof-of-concept study was performed in 32 HD patients allocated to 2 arms of 4 sequential 6-week periods each. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4612ae6b2eca528af7cdc517d8b7bd3a
https://pubmed.ncbi.nlm.nih.gov/36494329
https://pubmed.ncbi.nlm.nih.gov/36494329
Autor:
Oscar Huertas, Aileen Ferré, Kevin McAllister, Jaime Kulisevsky, Josep Gamez, Núria Reig, Raul Insa, Catherine Scart-Grès, Esteban Muñoz, Matilde Calopa
Publikováno v:
F: Clinical studies: case reports, observational studies and trials.
Background SOM3355 (bevantolol hydrochloride), a β1-adrenoceptor blocker used in hypertension, was identified as a vesicular monoamine transporter type 2 (VMAT2) inhibitor by artificial intelligence screening, and then selected by in vitro functiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53e684082dde644a3457b6b244fbaf99
https://doi.org/10.1136/jnnp-2021-ehdn.83
https://doi.org/10.1136/jnnp-2021-ehdn.83
Autor:
Catherine Scart-Grès, Jean-Charles Schwartz, Beatrice Setnik, Michael McDonnell, Philippe Robert, Jeffrey M Dayno, Catherine Mills
Publikováno v:
Sleep
Objectives To evaluate the human abuse potential of pitolisant, a selective histamine 3 (H3)-receptor antagonist/inverse agonist recently approved by the US Food and Drug Administration for the treatment of excessive daytime sleepiness in adult patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d41255da3cc89d999e760cdf32d7549
http://europepmc.org/articles/PMC7157189
http://europepmc.org/articles/PMC7157189
Publikováno v:
Médecine du Sommeil. 17:70
Objectif Etude conduite pour evaluer le potentiel d’abus du pitolisant (P), premier agoniste inverse du recepteur H3 de l’Histamine autorise dans le traitement de la narcolepsie avec ou sans cataplexie. Methodes Evaluation du potentiel d’abus d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e47dff70f7d37a03daee7a18b29bad7a
https://doi.org/10.1016/j.msom.2019.12.104
https://doi.org/10.1016/j.msom.2019.12.104
Autor:
Philippe Robert, Jean-Charles Schwartz, Beatrice Setnik, Catherine Scart-Grès, Jeffrey M Dayno
Publikováno v:
Sleep. 42:A243-A244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::605f9e8ca8ff76ae00e3ed5431164f13
https://doi.org/10.1093/sleep/zsz067.610
https://doi.org/10.1093/sleep/zsz067.610
Autor:
Michele Roy, Kiran Maski, Stèphane Piris, Richard K. Bogan, Chinedu Momah, Catherine Scart-Grès
Publikováno v:
Sleep. 42:A244-A245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f06a16030232e9c02ceb258f5f2b5b1
https://doi.org/10.1093/sleep/zsz067.612
https://doi.org/10.1093/sleep/zsz067.612
Autor:
Zoltan Szakacs, Isabelle Lecomte, C. Caussé, Jean-Charles Schwartz, Yves Dauvilliers, Catherine Scart-Grès, Isabelle Arnulf
Publikováno v:
Sleep. 41:A231-A232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::899d931fc78977d4fd357e79718ad11f
https://doi.org/10.1093/sleep/zsy061.622
https://doi.org/10.1093/sleep/zsy061.622
Autor:
Zoltan Szakacs, Isabelle Lecomte, Isabelle Arnulf, Yves Dauvilliers, Jean Schwartz, Catherine Scart-Grès
Publikováno v:
Médecine du Sommeil. 15:59-60
Objectif Pitolisant (P) demontra son efficacite dans la reduction de la somnolence diurne excessive et des cataplexies chez les patients adultes narcoleptiques (PAN). HARMONY III evalue l’efficacite et la tolerance de P jusqu’a 5 ans dont voici l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de175e3d9c8818bd615d990ccb32b689
https://doi.org/10.1016/j.msom.2018.01.162
https://doi.org/10.1016/j.msom.2018.01.162
Autor:
Isabelle Lecomte, Jean-Charles Schwartz, Kati Gutierrez, Zoltan Szakacs, Yves Dauvilliers, Catherine Scart-Grès, Isabelle Arnulf
Publikováno v:
Médecine du Sommeil. 14:48-49
Objectif Evaluer la tolerance et l’efficacite a long terme de pitolisant dans le traitement des patients narcoleptiques avec ou sans cataplexie. Methodes Suivi jusqu’a 5 ans de 104 patients narcoleptiques (ESS ≥12) traites par pitolisant jusqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c608a6ca543b1286668061e6be42c78e
https://doi.org/10.1016/j.msom.2017.01.092
https://doi.org/10.1016/j.msom.2017.01.092
Autor:
Jonas Mandel, Benoît Funalot, Laurent Magy, Odile Dubourg, Arnaud Lacour, Jean-Michel Vallat, Marie-Noëlle Lefebvre, Lamia Boudiaf, Marguerite Preudhomme, Mahmoud Al-Moussawi, Shahram Attarian, Daniel Cohen, Vincent Tiffreau, Pierre-Marie Gonnaud, Mickaël Guedj, Jérôme Franques, Rodolphe Hajj, Philippe Lehert, Jean Pouget, Catherine Scart-Grès, Armelle Magot, Yann Péréon, Ilya Chumakov, Walter Gilbert, Aude Milet, Laura Bossi, Tanya Stojkovic, Serguei Nabirotchkin, Karima Ghorab, Laurène Leclair-Visonneau, Viviane Bertrand, Joëlle Micallef
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol. 9, no.1, p. 199 (2014)
Orphanet Journal of Rare Diseases, Vol. 9, no.1, p. 199 (2014)
Background Charcot-Marie-Tooth type 1A disease (CMT1A) is a rare orphan inherited neuropathy caused by an autosomal dominant duplication of a gene encoding for the structural myelin protein PMP22, which induces abnormal Schwann cell differentiation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d82998f2043b10469b1df30f30ed1b1
https://doi.org/10.1186/s13023-014-0199-0
https://doi.org/10.1186/s13023-014-0199-0